![Margaret McGlynn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Margaret McGlynn
Vorsitzender bei
NOVAVAX, INC.
Vermögen: 418 889 $ am 30.06.2026
Profil
Margaret G.
McGlynn is currently Chairman at Novavax, Inc. since 2025, Chairman & President at HCU Network America since 2016, Director at Abington Friends School, Director at Life Science Cares Philadelphia, and Trustee at University at Buffalo Foundation, Inc. Former roles include President, Chief Executive Officer & Director at International AIDS Vaccine Initiative, Inc. from 2011 to 2015; Independent Director at Air Products & Chemicals, Inc. from 2005 to 2020; Director at Quidel Corp.; Independent Director at Vertex Pharmaceuticals, Inc. from 2011 to 2023; Director at GAVI Alliance from 2006 to 2008; Director at Orphan Technologies Ltd.; Independent Director at Amicus Therapeutics, Inc. from 2009 to 2026; President-Global Vaccines & Infectious Disease at Merck & Co., Inc. from 2006 to 2009; and President at US Department of Health & Human Services in 2005.
Education includes an undergraduate degree (1981) and an MBA (1983) from State University of New York at Buffalo.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVAVAX, INC. 0.03% | 20.06.2026 | 44’468 ( 0.03% ) | 418 889 $ | 30.06.2026 |
Aktive Positionen von Margaret McGlynn
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVAVAX, INC. | Vorsitzender | 10.03.2025 |
Abington Friends School
 Abington Friends School Other Consumer ServicesConsumer Services Provides primary and secondary education services | Direktor/Vorstandsmitglied | - |
HCU Network America
 HCU Network America Services to the Health IndustryHealth Services Provides support services for patients and families | Vorsitzender | 01.06.2016 |
Life Science Cares Philadelphia | Direktor/Vorstandsmitglied | - |
University at Buffalo Foundation, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Margaret McGlynn
| Unternehmen | Position | Ende |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 27.04.2026 |
| VERTEX PHARMACEUTICALS INCORPORATED | Direktor/Vorstandsmitglied | 17.05.2023 |
| AIR PRODUCTS & CHEMICALS, INC. | Direktor/Vorstandsmitglied | 23.11.2020 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Vorstandsvorsitzender | 08.09.2015 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Margaret McGlynn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Air Products & Chemicals, Inc.
 Air Products & Chemicals, Inc. Chemicals: SpecialtyProcess Industries Manufactures and supplies oxygen, nitrogen, argon, hydrogen, helium & carbon dioxide gases | Process Industries |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Provides diagnostic healthcare solutions | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
GAVI Alliance
 GAVI Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Department of Health & Human Services
 US Department of Health & Human Services General GovernmentGovernment Governmental department | Government |
University at Buffalo Foundation, Inc. | Consumer Services |
Abington Friends School
Abington Friends School Other Consumer ServicesConsumer Services Provides primary and secondary education services | Consumer Services |
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs | Health Technology |
HCU Network America
HCU Network America Services to the Health IndustryHealth Services Provides support services for patients and families | Health Services |
Life Science Cares Philadelphia |
